Sun Pharma Fact Sheet, Sun Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sun Pharma Fact Sheet    (SUNP)

Here is the latest financial fact sheet of Sun Pharma. For more details, see the Sun Pharma quarterly results and Sun Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

SUN PHARMA Price History

Price Rs 433.9
Mkt Cap Rs m 1,044,290
Vol '000 122.9
P/E X 21.5
P/CF X 21.0
EPS (TTM) Rs 20.2
% ch % -0.6
No. of shares m 2,406.75
% ch week % -5.1
% ch 1-mth % 0.9
% ch 12-mth % 4.9
52 week H/L Rs 484.1/350.4
(As on Dec 6, 2019 11:52:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SUN PHARMA Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
SUN PHARMA EQUITY SHARE DATA
High Rs1,0741,201842701679 
Low Rs570706572433375 
Sales per share (Unadj.) Rs132.3118.4131.6110.4121.1 
Earnings per share (Unadj.) Rs21.923.532.710.713.4 
Diluted earnings per shareRs18.923.532.610.713.3 
Cash flow per share (Unadj.) Rs27.727.837.917.020.7 
Dividends per share (Unadj.) Rs3.001.003.502.002.75 
Adj. dividends per shareRs2.581.003.491.992.74 
Dividend yield (eoy) %0.40.10.50.40.5 
Book value per share (Unadj.) Rs135.2137.1152.7159.7172.6 
Adj. book value per shareRs116.4137.0152.2159.2172.1 
Shares outstanding (eoy) m2,071.162,406.602,399.262,399.262,399.26 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.28.15.45.14.4 
Avg P/E ratio x37.540.621.753.039.4 
P/CF ratio (eoy) x29.734.318.633.425.5 
Price / Book Value ratio x6.17.04.63.53.1 
Dividend payout %13.74.310.718.720.6 
Avg Mkt Cap Rs m1,703,0112,294,8131,696,8771,360,0211,264,650 
No. of employees `000NA14.717.517.817.5 
Total wages/salary Rs m45,02647,72349,02353,67159,671 
Avg. sales/employee Rs ThNM19,317.218,028.314,890.916,608.1 
Avg. wages/employee Rs ThNM3,236.12,798.83,017.13,409.6 
Avg. net profit/employee Rs ThNM3,836.94,473.81,443.61,833.8 
SUN PHARMA INCOME DATA
Net Sales Rs m273,920284,870315,784264,895290,659 
Other income Rs m5,4776,5836,2328,38810,255 
Total revenues Rs m279,397291,453322,016273,282300,914 
Gross profit Rs m78,66781,583100,89356,08163,076 
Depreciation Rs m11,94710,37512,64814,99817,533 
Interest Rs m5,7905,2323,9985,1765,553 
Profit before tax Rs m66,40772,55890,47944,29550,246 
Minority Interest Rs m-9,3630000 
Prior Period Items Rs m-12615000 
Extraordinary Inc (Exp) Rs m-2,378-6,8520-9,505-12,144 
Tax Rs m9,1479,13812,1169,1106,009 
Profit after tax Rs m45,39456,58378,36325,67932,093 
Gross profit margin %28.728.631.921.221.7 
Effective tax rate %13.812.613.420.612.0 
Net profit margin %16.619.924.89.711.0 
SUN PHARMA BALANCE SHEET DATA
Current assets Rs m288,782299,413329,537316,359310,692 
Current liabilities Rs m153,294131,440178,870198,643173,396 
Net working cap to sales %49.559.047.744.447.2 
Current ratio x1.92.31.81.61.8 
Inventory Days Days7682799599 
Debtors Days Days688783108112 
Net fixed assets Rs m151,694180,477204,766213,178232,477 
Share capital Rs m2,0712,4072,3992,3992,399 
"Free" reserves Rs m278,009327,418363,997380,742411,691 
Net worth Rs m280,080329,825366,397383,141414,091 
Long term debt Rs m13,59831,10314,36117,72115,226 
Total assets Rs m501,601555,303614,102645,164646,938 
Interest coverage x12.514.923.69.610.0 
Debt to equity ratio x00.1000 
Sales to assets ratio x0.50.50.50.40.4 
Return on assets %10.211.113.44.85.8 
Return on equity %16.217.221.46.77.8 
Return on capital %20.519.724.810.010.2 
Exports to sales %16.913.9000 
Imports to sales %4.53.1000 
Exports (fob) Rs m46,23539,572000 
Imports (cif) Rs m12,2298,882000 
Fx inflow Rs m48,70642,17144,11851,40366,025 
Fx outflow Rs m25,56421,58324,48432,23338,610 
Net fx Rs m23,14220,58819,63419,17027,415 
SUN PHARMA CASH FLOW
From Operations Rs m 56,157 66,859 70,822 39,072 21,965 
From Investments Rs m -28,657 -43,716 -42,216 -33,708 -6,813 
From Financial Activity Rs m -11,865 -18,885 -22,854 -15,393 -27,305 
Net Cashflow Rs m 15,635 8,482 6,107 -7,359 -8,442 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 63.7%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.1%
FIIs 23.0%
ADR/GDR 0.0%
Free float 8.3%
Shareholders 133,026
Pledged promoter(s) holding 0.5%
 

Company Information

REGD OFF Sun Pharma Advanced Research Centre, Tandalja, Vadodara - 390 020
E-MAIL sunil.ajmera@sunpharma.com WEB www.sunpharma.com
TELEPHONE (022) 6696 9696 FAX (022) 2821 2010
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Deloitte Haskins & Sells
CHM: Israel Makov COMP SEC: Sunil R. Ajmera YEAR OF INC: 1993 BSE CODE: 524715 FV (Rs): 1 DIV YIELD (%): 0.6

Read: SUN PHARMA 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   AMAR REMEDIES  ALEMBIC LTD  STRIDES PHARMA SCIENCE  CIPLA  AJANTA PHARMA  

Compare SUN PHARMA With:   AMAR REMEDIES  ALEMBIC LTD  STRIDES PHARMA SCIENCE  CIPLA  AJANTA PHARMA  

Compare SUN PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Marginally Up; Metal and Banking Stocks Gain(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.1% while the Hang Seng is up 0.6%.

Views on news

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries? (Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade (The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market? (Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels Views On News (Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - ABBOTT INDIA COMPARISON

COMPARE SUN PHARMA WITH

MARKET STATS